| Date | Name | Shares | Transaction | Value |
|
Nov 6, 2025
| Charles R. Crisp Director |
62,841
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.84 per share |
6,651,091.44
|
|
Nov 6, 2025
| Robert P. Daniels Director |
32,135
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.84 per share |
3,401,168.40
|
|
Nov 6, 2025
| Michael P. Donaldson EVP & Chief Legal Officer |
96,583
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.84 per share |
10,222,344.72
|
|
Nov 6, 2025
| Janet F. Clark Director |
46,961
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.84 per share |
4,970,352.24
|
|
Oct 28, 2025
| Jeffrey R. Leitzell EVP & COO |
56,973
| Open market or private purchase of non-derivative security Non-derivative transaction at $107.97 per share |
6,151,374.81
|
|
Oct 28, 2025
| Jeffrey R. Leitzell EVP & COO |
56,969
| Open market or private purchase of non-derivative security Non-derivative transaction at $107.64 per share |
6,132,143.16
|
|
Oct 3, 2025
| Ann D. Janssen EVP & Chief Financial Officer |
100,143
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $113.35 per share |
11,351,209.05
|
|
Oct 3, 2025
| Ezra Y. Yacob Chairman & CEO; Director |
247,917
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $113.35 per share |
28,101,391.95
|
|
Oct 1, 2025
| Laura B. Distefano VP & CAO |
24,245
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 1, 2025
| Laura B. Distefano VP & CAO |
18,277
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Aug 20, 2025
| Charles R. Crisp Director |
62,544
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $119.99 per share |
7,504,654.56
|
|
Aug 20, 2025
| Charles R. Crisp Director |
62,455
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $120.02 per share |
7,495,849.10
|
|
Apr 4, 2025
| Jeffrey R. Leitzell EVP & COO |
51,769
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.04 per share |
6,628,502.76
|
|
Apr 4, 2025
| Jeffrey R. Leitzell EVP & COO |
51,732
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $127.89 per share |
6,616,005.48
|
|
Apr 4, 2025
| Jeffrey R. Leitzell EVP & COO |
47,732
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $127.76 per share |
6,098,240.32
|
|
Apr 4, 2025
| Jeffrey R. Leitzell EVP & COO |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Feb 5, 2025
| Lynn A. Dugle Director |
3,957
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $125.79 per share |
497,751.03
|
|
Feb 5, 2025
| Michael T. Kerr Director |
17,303
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $125.79 per share |
2,176,544.37
|
|
Feb 5, 2025
| Donald F. Textor Director |
169,928
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $125.79 per share |
21,375,243.12
|
|
Feb 5, 2025
| Christopher C. Gaut Director |
18,712
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $125.79 per share |
2,353,782.48
|